Psycho-Analytical Psychotherapy in the National Health Service

1967 ◽  
Vol 113 (496) ◽  
pp. 321-327 ◽  
Author(s):  
Thomas Freeman

It is a fact that there is, within the National Health Service, a gradually increasing demand for psycho-analytical psychotherapy. This demand is reflected in the large number of patients referred and in many articles dealing with the treatment of psychiatric and physical illnesses. Such satisfaction gained by this recognition is offset by the knowledge that both inside and outside the medical profession there is an abysmal ignorance of what psycho-analytical psychotherapy is, what it can or cannot achieve and what it involves in that most precious commodity—doctor time.

1980 ◽  
Vol 10 (4) ◽  
pp. 611-645 ◽  
Author(s):  

Many influential British groups have taken the opportunity provided by the Royal Commission on the National Health Service to put forward proposals which would fundamentally damage that service. In this paper we discuss the implications of some of these proposals, and explain why we defend the NHS as the basis of an equitable method of providing health care. We consider the various methods which have been suggested to increase the revenue of the NHS. We compare the experiences of several Western countries, and show that the method of financing inevitably affects the pattern of medical care and the indices of health and illness. We examine the underlying motives of many critics of the NHS, and document the development of private medicine in the United Kingdom. We continue by discussing ways in which less money could be spent on health care without detriment to the patient. As an example, we look at several surgical procedures in detail and demonstrate the costs of uncertainty in surgical practice. Finally, we consider the continuing power of the medical profession, how it is maintained, and its implications. We conclude by summarizing why we support the NHS despite its imperfections, and why attempts to undermine it should be resisted.


2000 ◽  
Vol 30 (2) ◽  
pp. 309-334 ◽  
Author(s):  
Steve Iliffe ◽  
James Munro

Britain's National Health Service (NHS) has been the subject of unprecedented market reforms, which have failed to solve its problems. The New Labour government elected in 1997 has halted the drive toward the marketization of health care and replaced cost with quality as the central concern of NHS administration and policy. Major changes are occurring in the regulation of professional activity, with profound implications for the medical profession and the health service. The authors discuss these changes and possible future problems for the NHS.


1989 ◽  
Vol 29 (2) ◽  
pp. 116-123 ◽  
Author(s):  
Jon B. Coldwell ◽  
Laurence J. Naismith

Records of 116 violent incidents perpetrated by special care patients over a twelve-month period were retrospectively examined. There was a marked seasonal variation in the number of incidents. Incidents took place predominantly in the seclusion rooms and in communal areas having relatively high patient density. Patients admitted from the National Health Service following unmanageable violent behaviour were over-represented. A small number of patients were responsible for a high proportion of incidents. Implications for prevention are discussed.


Author(s):  
Andrea Aiello ◽  
Maria Elisa Mancuso ◽  
Alessio Colombo ◽  
Cristina Teruzzi ◽  
Patrizia Berto

Introduction: Prophylaxis with factor IX (FIX) concentrates, produced by recombinant DNA technology (rFIX) or human plasma-derived concentrates, is the treatment of choice for haemophilia B (HB); rFIX covalently fused to the Fc domain of human immunoglobulin G1 (rFIXFc) allows for prophylaxis/treatment with one infusion every 7-14 days. The purpose of this study is to quantify the financial impact of prophylaxis with rFIXFc vs. other approved rFIX and reimbursed for treatment of HB in Italy. Methods: The number of patients was estimated according to Italian epidemiological data and use of rFIX. Dose and frequency of administration used for weekly prophylaxis were those recommended in the Summary of Product Characteristics (SPC), while clinical trials and literature data were used to calculate bleeding rates and management. Drug costs were calculated using regional ex-factory net prices. In the model, a reference scenario (Reference) vs. an alternative scenario (Alternative) were created to account for introduction of rFIXFc, estimating an increasing trend of the market share of rFIXFc in a 3-year timeframe. The analysis was developed in the perspective of the National Health Service and included healthcare costs related to rFIX for prophylaxis and resolution of bleeding events. Results: The model estimated an overall cumulative expenditure (years 1-3) of €209,453,646 for the Reference and €207,465,568 for Alternative scenarios, with calculated cumulative savings of €1,988,068. Conclusions: The increasing use of rFIXFc as a substitute for other rFIX concentrates in the treatment of HB can represent a financially viable choice for the Italian National Health Service while ensuring effective control of bleeding.


1983 ◽  
Vol 21 (21) ◽  
pp. 84.1-84

The NHS is a large and complicated organisation which is poorly understood by most of its users. Doctors and other workers in the NHS spend much time explaining relevant aspects of it to patients and their families. This Guide,1 produced by Consumers’ Association in collaboration with the Patients’ Association, should help patients to get the best from the NHS with the least difficulty. As Katharine Whitehorn writes in the foreword, ‘Informed patients can actually be of huge help to the medical profession and all workers in the Health Service, just because they know what is and isn’t reasonable, don’t expect the moon, and can contribute to their own cure by doing sensible things’.


2018 ◽  
Vol 212 (3) ◽  
pp. 175-179 ◽  
Author(s):  
Liam Trevithick ◽  
Jane Carlile ◽  
Sunil Nodiyal ◽  
Patrick Keown

BackgroundCommunity treatment orders (CTOs) were introduced in England in 2008.AimsTo measure the rate of CTO use in England during the first 5 years following introduction.MethodThe number of involuntary detentions and CTOs in National Health Service (NHS) hospital trusts was collected between 2009 and 2014. Rates of CTO use and the ratio of CTOs to detentions on admission were calculated, and how these varied between trusts.ResultsThe number of new CTOs each year ranged between 3834 and 4647. The number subject to a CTO per 100 000 population increased from 6.4 in 2009/10 to 10.0 in 2013/14. There was variation between NHS trusts in the use of CTOs when compared with the number of involuntary detentionsConclusionsThe number of patients on CTOs increased year on year. Those on forensic sections were more likely to be discharged on a CTO than those on civil sections. There was considerable variation in the pattern of use between hospitals.Declaration of interestNone.


Sign in / Sign up

Export Citation Format

Share Document